CONTINEUM THERAPEUTICS INC-A (CTNM) Forecast, Price Target & Analyst Ratings

NASDAQ:CTNM • US21217B1008

Current stock price

12.97 USD
+0.56 (+4.51%)
At close:
12.97 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONTINEUM THERAPEUTICS INC-A (CTNM).

Forecast Snapshot

Consensus Price Target

Price Target
$22.44
+ 73.01% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 14, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.15%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.44
Upside
+ 73.01%
From current price of $12.97 to mean target of $22.44, Based on 13 analyst forecasts
Low
$14.14
Median
$21.93
High
$30.45

Price Target Revisions

1 Month
8.20%
3 Months
8.20%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for CTNM. The average price target is 22.44 USD. This implies a price increase of 73.01% is expected in the next year compared to the current price of 12.97.
The average price target has been revised upward by 8.2% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CTNM Current Analyst RatingCTNM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

CTNM Historical Analyst RatingsCTNM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.15%
CTNM was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CTNM.
In the previous month the buy percentage consensus was at a similar level.
CTNM was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-06BairdMaintains Outperform -> Outperform
2026-01-08Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-11-24BairdMaintains Outperform -> Outperform
2025-11-21RBC CapitalMaintains Outperform -> Outperform
2025-09-25Leerink PartnersInitiate Outperform
2025-08-18Morgan StanleyMaintains Overweight -> Overweight
2025-05-19Morgan StanleyMaintains Overweight -> Overweight
2025-05-15RBC CapitalReiterate Outperform -> Outperform
2025-03-13Jones TradingInitiate Buy
2025-03-07BairdMaintains Outperform -> Outperform
2025-01-09RBC CapitalReiterate Outperform -> Outperform
2024-11-07RBC CapitalMaintains Outperform -> Outperform
2024-10-22BairdInitiate Outperform
2024-08-14RBC CapitalMaintains Outperform -> Outperform
2024-04-30RBC CapitalInitiate Outperform
2024-04-30StifelInitiate Buy
2024-04-30Morgan StanleyInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 14, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
12.57%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

CTNM is expected to report earnings on 5/14/2026. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CTNM revenue by date.CTNM revenue by date.
50M
-100.00%		6.12M2.244M
-63.33%		2.101M
-6.37%		17.782M
746.36%		19.427M
9.25%		24.736M
27.33%		103.62M
318.90%		351.59M
239.31%
EBITDA
YoY % growth
CTNM ebitda by date.CTNM ebitda by date.
-28.322M-22.391M
20.94%		16.272M
172.67%		-47.375M
-411.18%		-69.374M
-33.77%		-98.722M
-45.74%		-135.99M
-37.75%		-186.584M
-37.20%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
CTNM ebit by date.CTNM ebit by date.
-28.647M-22.72M
20.69%		16.077M
170.76%		-48.276M
-416.56%		-65.885M
-33.73%		-80.177M
-17.81%		-101.824M
-27.00%		-122.528M
-20.33%		-145.157M
-18.47%		-189.175M
-30.32%		-327.628M
-73.19%		-338.368M
-3.28%		-167.586M
50.47%
Operating Margin
CTNM operating margin by date.CTNM operating margin by date.
N/AN/A32.15%N/AN/A-1,310.08%-4,537.63%-5,831.90%-816.31%-973.77%-1,324.50%-326.55%-47.67%
EPS
YoY % growth
CTNM eps by date.CTNM eps by date.
N/AN/AN/A-1.95-2.11
55.51%		-2.10
3.82%		-2.22
-5.80%		-2.34
-5.52%		-2.49
-6.32%		-3.09
-23.98%		-3.94
-27.82%		-3.20
18.88%		-2.06
35.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.54
12.57%		-0.57
8.34%		-0.53
-17.87%		-0.57
-16.57%		-0.65
-20.43%		-0.66
-16.67%		-0.59
-11.54%		-0.64
-11.31%		-0.39
40.63%		-0.40
40.00%		-0.40
32.76%		-0.41
35.83%
Revenue
Q2Q % growth		5.763M10.2MN/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-23.062M
-27.90%		-24.284M
-36.85%		-26.118M
-27.88%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-19.116M
-5.56%		-20.857M
-16.51%		-20.381M
-4.61%		-18.217M
-37.04%		-29.571M
-54.69%		-32.244M
-54.60%		-35.172M
-72.57%		-38.375M
-110.66%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CTNM Yearly Revenue VS EstimatesCTNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CTNM Yearly EPS VS EstimatesCTNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-2.40%
EPS Next 5 Year
-7.19%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-41.48%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CONTINEUM THERAPEUTICS INC-A / CTNM Forecast FAQ

What is the average price target for CONTINEUM THERAPEUTICS INC-A (CTNM) stock?

13 analysts have analysed CTNM and the average price target is 22.44 USD. This implies a price increase of 73.01% is expected in the next year compared to the current price of 12.97.

What is the next earnings date for CTNM stock?

CONTINEUM THERAPEUTICS INC-A (CTNM) will report earnings on 2026-05-14.

What are the consensus estimates for CTNM stock next earnings?

The consensus EPS estimate for the next earnings of CONTINEUM THERAPEUTICS INC-A (CTNM) is -0.54 USD and the consensus revenue estimate is 0 USD.